Loading...
  • Twitter
  • Facebook
  • Google
  • Twitter
  • Facebook
  • Google
fr

News

Articles dans la catégorie "Biotechnologie"
Posté: il y a 2 heures
The FDA has awarded Hansa Medical’s lead candidate for the treatment of an autoimmune disease affecting the peripheral nervous system with Orphan Drug Designation. Swedish biotech, Hansa Medical...
Posté: il y a 2 heures
Two clinical studies have demonstrated the capacity of Novartis’ monoclonal antibody to treat both plaque and scalp psoriasis and improve patient quality of life.  Not only is Novartis leading t...
Posté: il y a 5 heures
UCB has achieved positive Phase IIb and III results for its psoriasis drug, bimekizumab, which were presented at the American Academy of Dermatology’s annual meeting. Belgian biopharma, UCB, dev...
Posté: il y a 7 heures
Scientists in London are the first in the world to test how pathogens like the hepatitis B virus interact with artificial human organs. Researchers at Imperial College London have used artificial huma...
Posté: il y a 10 heures
CAR-T cells are all the rage as the latest treatment for cancer. But what if we could apply this same technology to treat autoimmune disease? Curious to learn whether this new technology could revolut...
Posté: Février 16
Try as we might, we can’t cover all the biotech news out there! This week has been intense for biotech finance with multiple deals and fundraisings announced. Oxford-based Scancell will use ISA Pharma...
Posté: Février 16
Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to use CRISPR technology to make CAR-T cells. Cellectis has said it will offer licenses to co...
Posté: Février 16
This week, we’re in the Bavarian region of Germany to check out XL-Protein, a biotech that improves drug delivery by modifying the drugs we use to help them stay in the body for longer. Mission:...
Posté: Février 15
The wireless system for diabetes management developed by Cellnovo can significantly reduce life-threatening events of hypoglycemia in patients with type 1 diabetes.  A clinical study that followed typ...
Posté: Février 15
iBionext has closed its Growth Fund, which has raised money from investors like Bpifrance to help young biotechs to reach their potential. iBionext is a French ‘startup studio’ that specia...
Pages : 1 2 3 4 5 6 7 8 9 10 ... » »»